Zoekresultaten - Paradisi, Stefania
- Toon 1 - 3 resultaten van 3
-
1
New schedule of bevacizumab/paclitaxel as first‐line therapy for metastatic HER2‐negative breast cancer in a real‐life setting door Cannita, Katia, Paradisi, Stefania, Cocciolone, Valentina, Bafile, Alberto, Rinaldi, Lucia, Irelli, Azzurra, Lanfiuti Baldi, Paola, Zugaro, Luigi, Manetta, Rosa, Alesse, Edoardo, Ricevuto, Enrico, Ficorella, Corrado
Gepubliceerd in 2016Text -
2
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis door Cocciolone, Valentina, Cannita, Katia, Calandrella, Maria Letizia, Ricevuto, Enrico, Baldi, Paola Lanfiuti, Sidoni, Tina, Irelli, Azzurra, Paradisi, Stefania, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Tessitore, Alessandra, Ficorella, Corrado
Gepubliceerd in 2017Text -
3
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations door Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
Gepubliceerd in 2018Text